Many studies have found that CD36 is involved in lipid metabolism disorder, such as metabolic syndrome (MS), nonalcoholic fatty liver disease (NAFLD) [9, 10]. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.